Hannah Spielmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hannah Spielmann has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Christiane Kugler
Faculty of Medicine, Institute of Nursing Science, University of Freiburg, Freiburg, Germany
6 shared publications Katharina Tigges-Limmer
Heart and Diabetes Center North-Rhine Westphalia, University Hospital of the Ruhr University Bochum, Bad Oeynhausen, Germany
4 shared publicationsWolfgang Albert
Department of Cardiothoracic and Vascular Surgery German Heart Center Charité Berlin Germany
4 shared publicationsChristine Spitz-Köberich
Medical Center - University of Freiburg, University Heart Center Freiburg - Bad Krozingen; Germany
3 shared publications- Paulina Staus
Institute of Medical Biometry and Statistics, Division Methods in Clinical Epidemiology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
3 shared publications Volker Lauenroth
Heart and Diabetes Center North‐Rhine Westphalia University Hospital of the Ruhr University Bochum Bad Oeynhausen Germany
3 shared publications
Latest Publications
- Open Access
- 3 December 2024
- Published by Wiley in Artificial Organs
- Vol. 49 (3) , 373-389
Curricular Self‐management for patients on ventricular assist device support decreases depression: A multicenter randomized controlled trial
Background: Utilization of ventricular assist device (VAD) support in patients with end‐stage heart failure is well advanced. Recent studies emphasize the need to develop and evaluate evidence‐based psychosocial support interventions for patients following VAD implantation.Methods: A national, multi‐center study in four established German heart centers was initiated. An evidence‐based VAD curriculum was developed; a randomized controlled trial evaluated the impact of the interprofessional intervention over time. Primary combined endpoint was the occurrence of adverse events (thromboembolic events, driveline infections, bleeding, rehospitalization, and death); secondary endpoints were psychosocial outcomes (anxiety, depression [HADS], quality of life [QoLVAD], social support [FSoZu], and self‐management [SELMA]). A total of 140 patients were randomized block‐wise to intervention (IG n = 70) or control (CG n = 70). Center‐effects were considered. Instruments were completed at four time points (T0‐T3).Results: At baseline, intervention group (IG) patients were 19% female (control group [CG] 19%; p = 0.982); 58 ± 11 years. (CG 58 ± 11 years.; p = 0.966); 80% were implanted electively (CG 79%; p = 0.968). No significant difference in primary endpoint was found between IG versus CG (p > 0.05). For secondary endpoints, mixed linear regression revealed a significant reduction in depression scores in IG compared to CG (est. 1.18; 95% CI −2.17 to −0.18; p = 0.021). Clinically significant reductions in anxiety were greater in IG patients between T0 and T3 (IG 51.9%; CG 40.7%); increased anxiety was reported in 3.7% IG (11.1% CG). Mixed linear regression analyses favored IG (all >0.05) for QoL, social support, and self‐management.Conclusion: A comprehensive curricular VAD intervention has potential to decrease depression levels and improve psychosocial outcomes of patients on VAD support.
- 3 December 2024
- Published by Wiley in Artificial Organs
- Vol. 49 (3) , 373-389
Open AccessCurricular Self‐management for patients on ventricular assist device support decreases depression: A multicenter randomized controlled trial
Background: Utilization of ventricular assist device (VAD) support in patients with end‐stage heart failure is well advanced. Recent studies emphasize the need to develop and evaluate evidence‐based psychosocial support interventions for patients following VAD implantation.Methods: A national, multi‐center study in four established German heart centers was initiated. An evidence‐based VAD curriculum was developed; a randomized controlled trial evaluated the impact of the interprofessional intervention over time. Primary combined endpoint was the occurrence of adverse events (thromboembolic events, driveline infections, bleeding, rehospitalization, and death); secondary endpoints were psychosocial outcomes (anxiety, depression [HADS], quality of life [QoLVAD], social support [FSoZu], and self‐management [SELMA]). A total of 140 patients were randomized block‐wise to intervention (IG n = 70) or control (CG n = 70). Center‐effects were considered. Instruments were completed at four time points (T0‐T3).Results: At baseline, intervention group (IG) patients were 19% female (control group [CG] 19%; p = 0.982); 58 ± 11 years. (CG 58 ± 11 years.; p = 0.966); 80% were implanted electively (CG 79%; p = 0.968). No significant difference in primary endpoint was found between IG versus CG (p > 0.05). For secondary endpoints, mixed linear regression revealed a significant reduction in depression scores in IG compared to CG (est. 1.18; 95% CI −2.17 to −0.18; p = 0.021). Clinically significant reductions in anxiety were greater in IG patients between T0 and T3 (IG 51.9%; CG 40.7%); increased anxiety was reported in 3.7% IG (11.1% CG). Mixed linear regression analyses favored IG (all >0.05) for QoL, social support, and self‐management.Conclusion: A comprehensive curricular VAD intervention has potential to decrease depression levels and improve psychosocial outcomes of patients on VAD support.
- Open Access
- 3 January 2024
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 70 (5) , 348-355
Professional Employment in Patients on Ventricular Assist Device Support—A National Multicenter Survey Study
This study aimed to assess patients of working age returning to professional employment as a surrogate marker for functional recovery and psychosocial reintegration after ventricular assist device (VAD) implantation. A national, multicenter study considered professional employment and its relationship to sociodemographic, psychosocial, and clinical adverse outcomes in outpatients on VAD support. Patient-reported outcome measures were administered. The survey had a 72.7% response rate. Mean age of 375 subjects was 58 ± 11 years, 53 (14%) were female. Thirty-five patients (15.15%; 95% confidence interval [CI] = 10.9–20.6) were employed, and the majority of them (n = 29, 82.9%) were bridged to transplantation. A regression model after variable selection revealed younger age (odds ratio [OR] = 0.95; 95% CI = 0.91–0.98; p < 0.005), and higher education (OR = 3.05; 95% CI = 1.72–5.41; p < 0.001) associated with professional employment. Employed patients reported higher health-related quality of life (HRQoL) (Kansas City Cardiomyopathy Questionnaire [KCCQ] overall sum-score, OR = 1.04; 95% CI = 0.92–1.07; p < 0.007), the OR for those employed was 2.18 (95% CI = 0.89–5.41; p < 0.08) indicating no significant relation for employment and a history of adverse events. In this sample, professional employment was rather small; the likelihood of adverse events was not significantly different between groups. Those employed perceived better overall HRQoL, which may encourage clinicians to support professional employment for selected patients on VAD support.
- 3 January 2024
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 70 (5) , 348-355
Open AccessProfessional Employment in Patients on Ventricular Assist Device Support—A National Multicenter Survey Study
This study aimed to assess patients of working age returning to professional employment as a surrogate marker for functional recovery and psychosocial reintegration after ventricular assist device (VAD) implantation. A national, multicenter study considered professional employment and its relationship to sociodemographic, psychosocial, and clinical adverse outcomes in outpatients on VAD support. Patient-reported outcome measures were administered. The survey had a 72.7% response rate. Mean age of 375 subjects was 58 ± 11 years, 53 (14%) were female. Thirty-five patients (15.15%; 95% confidence interval [CI] = 10.9–20.6) were employed, and the majority of them (n = 29, 82.9%) were bridged to transplantation. A regression model after variable selection revealed younger age (odds ratio [OR] = 0.95; 95% CI = 0.91–0.98; p < 0.005), and higher education (OR = 3.05; 95% CI = 1.72–5.41; p < 0.001) associated with professional employment. Employed patients reported higher health-related quality of life (HRQoL) (Kansas City Cardiomyopathy Questionnaire [KCCQ] overall sum-score, OR = 1.04; 95% CI = 0.92–1.07; p < 0.007), the OR for those employed was 2.18 (95% CI = 0.89–5.41; p < 0.08) indicating no significant relation for employment and a history of adverse events. In this sample, professional employment was rather small; the likelihood of adverse events was not significantly different between groups. Those employed perceived better overall HRQoL, which may encourage clinicians to support professional employment for selected patients on VAD support.
- Open Access
- 22 November 2023
- Published by Wolters Kluwer Health in Journal of Cardiovascular Nursing
- Vol. 39 (6) , 571-582
Health-Related Quality of Life in Patients With Ventricular Assist Device
Background: Ventricular assist device (VAD) implantation has become an alternative treatment for patients with end-stage heart failure. In Germany, valid and reliable instruments to assess health-related quality of life in patients with VAD are lacking. Objective: The aim of this study was to present the psychometric validation of the German version of the Quality of Life with a Ventricular Assist Device questionnaire. Methods: In a multicenter, cross-sectional study, 393 participants (mean age, 58.3 years; 85.8% male, 60.3% bridge to transplant, and 72.8% living with VAD for ≤2 years) completed the German Quality of Life with a Ventricular Assist Device questionnaire of physical, emotional, social, cognitive, and meaning/spiritual domains. Item and confirmatory factor analyses were conducted to test item difficulty and discrimination and the underlying structure, respectively. To examine internal consistency, Cronbach α was assessed. Convergent construct validity was tested using the Kansas City Cardiomyopathy Questionnaire and the Patient Health Questionnaire-9. Readability was examined using Flesch Reading Ease index and Vienna Factual Text Formula. Results: The Quality of Life with a Ventricular Assist Device showed reasonable item difficulty (P total = .67) and mostly moderate to high discriminatory power (r it > 0.30). In confirmatory factor analysis, root-mean-square error of approximation (0.07) was acceptable for model fit, but no other indices. Acceptable internal consistency was found (α ≥ 0.79), with the exception of the cognitive domain (α = 0.58). The overall questionnaire and single domains demonstrated convergent validity (r ≥ 0.45, P < .001). The questionnaire showed adequate readability (Flesch Reading Ease, 64.11; Vienna Factual Text Formula, 6.91). Conclusion: Findings indicate a promising standardized clinical instrument to assess health-related quality of life in patients with VAD.
- 22 November 2023
- Published by Wolters Kluwer Health in Journal of Cardiovascular Nursing
- Vol. 39 (6) , 571-582
Open AccessHealth-Related Quality of Life in Patients With Ventricular Assist Device
Background: Ventricular assist device (VAD) implantation has become an alternative treatment for patients with end-stage heart failure. In Germany, valid and reliable instruments to assess health-related quality of life in patients with VAD are lacking. Objective: The aim of this study was to present the psychometric validation of the German version of the Quality of Life with a Ventricular Assist Device questionnaire. Methods: In a multicenter, cross-sectional study, 393 participants (mean age, 58.3 years; 85.8% male, 60.3% bridge to transplant, and 72.8% living with VAD for ≤2 years) completed the German Quality of Life with a Ventricular Assist Device questionnaire of physical, emotional, social, cognitive, and meaning/spiritual domains. Item and confirmatory factor analyses were conducted to test item difficulty and discrimination and the underlying structure, respectively. To examine internal consistency, Cronbach α was assessed. Convergent construct validity was tested using the Kansas City Cardiomyopathy Questionnaire and the Patient Health Questionnaire-9. Readability was examined using Flesch Reading Ease index and Vienna Factual Text Formula. Results: The Quality of Life with a Ventricular Assist Device showed reasonable item difficulty (P total = .67) and mostly moderate to high discriminatory power (r it > 0.30). In confirmatory factor analysis, root-mean-square error of approximation (0.07) was acceptable for model fit, but no other indices. Acceptable internal consistency was found (α ≥ 0.79), with the exception of the cognitive domain (α = 0.58). The overall questionnaire and single domains demonstrated convergent validity (r ≥ 0.45, P < .001). The questionnaire showed adequate readability (Flesch Reading Ease, 64.11; Vienna Factual Text Formula, 6.91). Conclusion: Findings indicate a promising standardized clinical instrument to assess health-related quality of life in patients with VAD.
- 3 November 2023
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 43 (8) , 1241-1248
Disturbance in bodily experience following ventricular assist device implantation
- 3 November 2023
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 43 (8) , 1241-1248
Disturbance in bodily experience following ventricular assist device implantation
- Open Access
- 12 October 2023
- Published by Elsevier in Heart & Lung
- Vol. 63, 92-97
High level of psychosocial adjustment in patients on ongoing ventricular assist device support in the years one to three after VAD implantation—A national multi-center Study
- 12 October 2023
- Published by Elsevier in Heart & Lung
- Vol. 63, 92-97
Open AccessHigh level of psychosocial adjustment in patients on ongoing ventricular assist device support in the years one to three after VAD implantation—A national multi-center Study
- Open Access
- 1 May 2021
- Published by Elsevier in Heart & Lung
- Vol. 50 (3) , 388-396
Self-management with the therapeutic regimen in patients with ventricular assist device (VAD) support – a scoping review
- 1 May 2021
- Published by Elsevier in Heart & Lung
- Vol. 50 (3) , 388-396
Open AccessSelf-management with the therapeutic regimen in patients with ventricular assist device (VAD) support – a scoping review